These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4704920)

  • 1. The usefulness of laboratory tests in health-screening programs.
    Sackett DL
    Clin Chem; 1973 Apr; 19(4):366-72. PubMed ID: 4704920
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple contributors to coronary risk implications for screening and prevention.
    Gordon T; Kannel WB
    J Chronic Dis; 1972 Nov; 25(10):561-5. PubMed ID: 4647218
    [No Abstract]   [Full Text] [Related]  

  • 3. On improving the diagnostic value of quantitative medical laboratory tests in health screening.
    Weldon KL; MacKay JS
    J Chronic Dis; 1972 Dec; 25(12):697-709. PubMed ID: 4648514
    [No Abstract]   [Full Text] [Related]  

  • 4. The cost of screening.
    Grieve RJ
    N Z Med J; 1977 Dec; 86(601):537. PubMed ID: 272576
    [No Abstract]   [Full Text] [Related]  

  • 5. Models for the evaluation of pre-hospital coronary care.
    Sidel VW; Acton J; Lown B
    Am J Cardiol; 1969 Nov; 24(5):674-88. PubMed ID: 5347941
    [No Abstract]   [Full Text] [Related]  

  • 6. Current trends and problems in health screening.
    Wilson JM
    J Clin Pathol; 1973 Aug; 26(8):555-63. PubMed ID: 4593600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for the early detection of disease, the need for evidence.
    McQueen MJ
    Clin Chim Acta; 2002 Jan; 315(1-2):5-15. PubMed ID: 11728406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methods of mass early detection and prevention of atherosclerosis (especially ischemic cardiopathy)].
    Steinbach M; Popescu I; Constantineanu M; Harnagea P; Teodorini S
    Stud Cercet Med Interna; 1970; 11(4):323-43. PubMed ID: 5474705
    [No Abstract]   [Full Text] [Related]  

  • 9. Heart disease prevention in industry. Primary prevention in mass community efforts to control the major coronary risk factors: the challenges and possibilities--critical issues and outlook for the future.
    Stamler J
    J Occup Med; 1973 Jan; 15(1):54-9. PubMed ID: 4684730
    [No Abstract]   [Full Text] [Related]  

  • 10. Value of new laboratory tests in diagnosis and treatment.
    Holland WW; Whitehead TP
    Lancet; 1974 Aug; 2(7877):391-4. PubMed ID: 4137352
    [No Abstract]   [Full Text] [Related]  

  • 11. Utility of multiphasic biochemical screening and systemic laboratory investigations.
    Werner M; Altshuler CH
    Clin Chem; 1979 Apr; 25(4):509-11. PubMed ID: 466757
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing systemic disease risk in a dental setting: a public health perspective.
    Greenberg BL; Glick M
    Dent Clin North Am; 2012 Oct; 56(4):863-74. PubMed ID: 23017556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coronary angioplasty: use and cost].
    Bossi I; De Servi S; Bramucci E; Angoli L
    G Ital Cardiol; 1997 May; 27(5):489-94. PubMed ID: 9244756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular screening to assess risk of coronary heart disease.
    Doyle JT; Kinch SH; Brown DF
    Public Health Rep (1896); 1968 Aug; 83(8):659-67. PubMed ID: 4969745
    [No Abstract]   [Full Text] [Related]  

  • 15. [Follow-up study on a model preventive study. An empirical investigation].
    Böck D; Rommel K; Schröder R
    Med Welt; 1979 Nov; 30(44):1637-41. PubMed ID: 530064
    [No Abstract]   [Full Text] [Related]  

  • 16. Cholesterol and coronary heart disease: screening and treatment.
    Ebrahim S; Smith GD; McCabe C; Payne N; Pickin M; Sheldon TA; Lampe F; Sampson F; Ward S; Wannamthee G
    Qual Health Care; 1998 Dec; 7(4):232-9. PubMed ID: 10339027
    [No Abstract]   [Full Text] [Related]  

  • 17. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
    Pelczarska A; Jakubczyk M; Jakubiak-Lasocka J; Banach M; Myśliwiec M; Gruchała M; Niewada M
    Atherosclerosis; 2018 Mar; 270():132-138. PubMed ID: 29407882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practice research. Screening in general practice: implications for cost and extra work.
    Grace JF
    Br Med J (Clin Res Ed); 1983 Aug; 287(6392):589-90. PubMed ID: 6411239
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ischemic heart disease risk factors in students].
    Abaĭkhanova FI; Zhanpeisova AA; Glazunov IS
    Ter Arkh; 1986; 58(5):62-5. PubMed ID: 2943042
    [No Abstract]   [Full Text] [Related]  

  • 20. High risk subjects and the cost of large field trials.
    Sondik EJ; Brown BW; Silvers A
    J Chronic Dis; 1974 Jul; 27(4):177-87. PubMed ID: 4843251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.